Page 1

Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 Form 10 - K ( Mark One ) > ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number : 001-39186 ARCUTIS BIOTHERAPEUTICS , INC . ( Exact name of registrant as specified in its charter ) Delaware ( State or Other Jurisdiction of Incorporation or Organization ) 3027 Townsgate Road Suite 300 Westlake Village , California ( Address of Principal Executive Offices ) Title of each class Common Stock , par value $ 0.0001 ( 805 ) 418-5006 ( Registrant's telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol ARQT Large accelerated filer Non - accelerated filer ( I.R.S. Employer Identification Number ) 91361 ( Zip Code ) 81-2974255 Securities registered pursuant to section 12 ( g ) of the Act : None Indicate by a check mark if the Registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes > No Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes No Indicate by check mark whether the Registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the Registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Name of each exchange on which registered The Nasdaq Global Select Market Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the Registrant was required to submit such files ) . Yes No 00 Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer " , " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Accelerated filer Smaller reporting company 冈 □ ☑ Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) : Yes No X The approximate aggregate market value of voting and non - voting stock held by non - affiliates of the registrant was $ 619,916,280 as of June 30 , 2020 . The number of shares of the registrant's Common Stock outstanding as of February 11 , 2021 was 50,084,677 . DOCUMENTS INCORPORATED BY REFERENCE : Portions of the registrant's Proxy Statement for the registrant's 2021 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10 - K to the extent stated herein . The Proxy Statement will be filed within 120 days of the registrant's fiscal year ended December 31 , 2020 .